An interventional study of MyPath Web-Based Informational and Decision Support Tool in Contraception, Contraception Behavior and Prepregnancy Health, sponsored by VA Office of Research and Development. Completed at 12 sites in United States. Open to female participants aged 18 Years to 44 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-11-06.
Sponsored by VA Office of Research and Development · Not applicable, Interventional, and Health services research
The investigators have developed a web-based decision support tool to help women Veterans get the information and care they need to achieve their reproductive goals, whether that includes optimizing their health before desired pregnancies or birth control to avoid unwanted pregnancies. The study will test the effect of sending a weblink to the decision tool to women Veterans prior to primary care visits at the VA. Half of participants will be sent a weblink before their appointment, and half will not be sent the link. The investigators hypothesize that participants who are sent the link will be more likely to report patient-centered discussions of their reproductive needs at visits, feel confident in communicating with their health care providers, have accurate knowledge about reproductive health, and choose birth control methods that best fit their preferences and needs.
Counseling and care that supports individuals' ability to achieve their reproductive goals is an essential component of primary care. National organizations, including the Centers for Disease Control and Prevention (CDC), recommend that clinicians routinely engage in patient-centered conversations about reproductive goals and offer care to help optimize health and well-being prior to desired pregnancies and to prevent unwanted pregnancy and births. This counseling is particularly critical for women Veterans, who face elevated risks of adverse pregnancy and birth outcomes due to a high prevalence of chronic medical and mental health conditions as well as psychosocial stressors including sexual trauma histories, intimate partner violence, and homelessness. Moreover, stark racial/ethnic disparities in pregnancy outcomes are well-documented, and nearly half of reproductive-aged women Veterans are minority race/ethnicity. Despite these national recommendations, however, conversations about reproductive needs are often absent in primary care both outside and within the VA, and the conversations that do happen frequently fail to incorporate women's values and preferences. Interventions are needed to improve both the frequency and quality of counseling about reproductive needs in primary care settings.
This study will investigate the effect of a novel, web-based, patient-facing decision support tool designed to be used prior to VA primary care visits to help women Veterans with reproductive capacity consider their reproductive goals; improve their knowledge about fertility, contraception, and prepregnancy health risks; align contraceptive decisions with their preferences and goals; and engage in shared decision making (SDM) with providers.
The investigators will conduct a multi-site randomized controlled trial (RCT) clustered at the provider level among VA primary care providers and their reproductive-aged women Veteran patients. Study outcomes will be assessed among participants shortly after their scheduled appointment and at 3- and 6-months follow up. The study will test the primary hypothesis that participants who receive the tool weblink prior to visits will be more likely to report patient-centered conversations about their reproductive needs at their visit. The investigators also hypothesize that intervention participants will report higher perceived self-efficacy in communicating with providers, reproductive health knowledge, contraception decision quality, and contraception utilization. Exploratory outcomes include behaviors to modify preconception health risks among participants considering pregnancy in the future and intervention effects by race/ethnicity. The study will also collect quantitative and qualitative data to assess the feasibility of implementing the tool more widely in VA primary care settings.
Patients:
Providers:
Exclusion Criteria:
Patients:
Providers:
Patients scheduled to see providers randomized to this arm will receive a weblink to the decision tool via text message after study enrollment and prior to their scheduled visit.
Behavioral: MyPath Web-Based Informational and Decision Support Tool
Patients scheduled to see providers randomized to the usual care arm will receive no intervention and will receive usual primary care.
The MyPath Decision Support Tool includes the following sections and features: * Questions to capture reproductive goals and orientations towards a potential pregnancy * Education modules about the menstrual cycle, fertility, and prepregnancy health with the opportunity to flag topics that are relevant and of interest to the patient * A contraceptive decision module that provides education, elicits patient preferences about different aspects of contraception, and suggests methods most appropriate based on the patient's preferences * A feature for adding free-text questions that patients may have for their provider * An email with a summary page that the patient can bring to a visit to guide discussions with primary care providers about reproductive needs
Occurrence of Reproductive Needs Discussion With Shared Decision Making (SDM)
Self-report of whether a discussion occurred during the scheduled primary care visit about pregnancy goals, prepregnancy health, or contraception that included shared decision making (SDM). SDM is measured by participant self-report with the CollaboRATE scale, which uses three 5-point Likert scale questions to assess SDM (score 0-12, with higher scores indicating more shared decision making; SDM defined using a top box score).
Time frame: Within one month post-visit
Occurrence of Reproductive Needs Discussion
Self-report of whether a discussion of pregnancy goals, prepregnancy health, or contraception occurred during the scheduled primary care visit, regardless of occurrence of SDM.
Time frame: Within one month post-visit
Perceived Self-efficacy in Communicating With Providers
Assessed with a modified version of the validated 5-item Perceived Efficacy in Patient-Provider Interactions (PEPPI) scale, which uses five Likert scale questions ranging from 1 to 5 (score 5-25, with higher scores indicating higher levels of perceived efficacy).
Time frame: Within one month post-visit
Reproductive Health Knowledge
Participant responses to 14 items assessing knowledge of fertility, prepregnancy health, and contraception. The measure is self-developed and derived from previously published assessments of fertility and contraceptive knowledge. Responses will be coded as correct vs. incorrect, with "don't know" coded as incorrect (score 0-14, with higher scores indicating more accurate knowledge).
Time frame: Within one month post-visit
Contraceptive Decision Conflict
Assessed with the Decision Conflict Scale (DCS), a validated measure to assess patients' decisional conflict in medical decision making. The DCS includes 16-items with 5-point Likert scale response options ranging from 0-4. Scores are converted to range from 0 (no decisional conflict) to 100 (highest decisional conflict). This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy.
Time frame: Within one month post-visit
Confidence That Contraceptive Method is "Right for me."
Assessed using a single question ("How confident are you that this contraceptive method is right for you?") with Likert response options from 1 (not at all confident) to 5 (completely confident). This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy.
Time frame: Within one month post-visit
Choice of Prescription or Procedural Contraceptive Method
Self-report of continuing or changing to a prescription or procedural method after their visit. Prescription or procedural methods are defined as any of the following: birth control pills, patch, ring, injection, implants, IUDs, and male and female sterilization. This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy.
Time frame: Within one month post-visit
Choice of Procedural Contraceptive Method
Self-report of continuing or changing to a procedural method after their visit. Procedural methods are defined as any of the following: implants, IUDs, and male and female sterilization. This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy.
Time frame: Within one month post-visit
Use of Prescription or Procedural Contraceptive Method
Self-reported use of a prescription or procedural method at follow-up. Prescription or procedural methods are defined as any of the following: birth control pills, patch, ring, injection, implants, IUDs, and male and female sterilization. This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy.
Time frame: 6 months
Use of Procedural Contraceptive Method
Self-reported use of a procedural method at follow-up. Procedural methods are defined as any of the following: implants, IUDs, and male and female sterilization. This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy.
Time frame: 6 months
Continuous Use of Any Contraception
Self-reported use of a contraceptive method over the past 6 months without a gap of greater than 4 weeks. This combines self-reported use at 3 months and 6 months. This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy. For participants lost to follow-up at the 6 month timepoint, their 6-month values will be singly imputed, carrying forward 3-month continuous use reports when those data are available.
Time frame: 6 months
Continuous Use of Prescription or Procedural Contraception
Self-reported use of a prescription or procedural contraceptive method over the past 6 months without a gap of greater than 4 weeks. Prescription or procedural methods are defined as any of the following: birth control pills, patch, ring, injection, implants, IUDs, and male and female sterilization. This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy.
Time frame: 6 months
Continuous Use of Procedural Contraception
Self-reported use of a procedural contraceptive method over the past 6 months without a gap of greater than 4 weeks. Procedural methods are defined as any of the following: implants, IUDs, and male and female sterilization. This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy.
Time frame: 6 months
Contraceptive Method Satisfaction
Assessed using a single question ("How satisfied are you with your current birth control method") with Likert response options from 1 (very dissatisfied) to 5 (very satisfied). This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy. While this outcome was measured at 6 months, for participants lost to follow-up at 6 months, we singly imputed these data by pulling forward their 3-month satisfaction, when available.
Time frame: 6 months
Incidence of Unplanned Pregnancy
Proportion of participants who self-report an unplanned pregnancy, as determined by responses to the 6-item London Measure of Unplanned Pregnancy. The London Measure includes items measuring attitude towards an experienced pregnancy and behaviors before pregnancy to determine the intendedness of pregnancy. The score range of the London Measure is 0-12, with a score of \<10 indicating unplanned pregnancy and a score of 10 or higher indicating planned pregnancy. This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy.
Time frame: 6 months
Confidence That Current Contraceptive Method is "Right for me."
Assessed using a single question ("How confident are you that this contraceptive method is right for you?") with Likert response options from 1 (not at all confident) to 5 (completely confident). This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy.
Time frame: 6 months
Goals-concordant Contraceptive Use
Self-reported contraception use among participants at 6 months that is consistent with their orientation towards pregnancy at 6-months (desires pregnancy now, not trying but OK with it, desires pregnancy later but not now, never desires pregnancy, not sure), regardless of their intention at baseline. This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy. For Veterans who desire pregnancy now, goals-concordant contraceptive use is defined as not using contraception. For Veterans who desire pregnancy later, never, or are unsure, goals-concordant contraceptive use is defined as using contraception. For Veterans who are not trying to get pregnant but would be OK with it, goals-concordant contraceptive use is defined as either using or not using contraception.
Time frame: 6 months
Contraceptive Knowledge
Participant responses to 8 items assessing knowledge of contraception. The measure derived from previously published assessments of contraceptive knowledge. Responses will be coded as correct vs. incorrect, with "don't know" coded as incorrect (score 0-8, with higher scores indicating more accurate knowledge).
Time frame: Within one month post-visit
VA primary care providers from 12 VA healthcare systems were enrolled and randomized to the intervention or control arm of the study. Veteran patients were subsequently recruited and enrolled into the study if they had an upcoming, scheduled appointment with a study provider. Veterans were automatically assigned to the study arm of the provider they were scheduled to see.
| Milestone | Intervention (MyPath) | Usual Care Patients |
|---|---|---|
| Started | 209 | 182 |
| Completed | 190 | 159 |
| Not completed | 19 | 23 |
| Withdrew: Withdrawal by subject | 3 | 4 |
| Withdrew: Did not attend scheduled appointment with primary care provider | 16 | 18 |
| Withdrew: Pregnancy | 0 | 1 |
| Milestone | Intervention (MyPath) | Usual Care Patients |
|---|---|---|
| Started | 190 | 159 |
| Completed | 188 | 158 |
| Not completed | 2 | 1 |
| Withdrew: Withdrawal by subject | 2 | 1 |
| Milestone | Intervention (MyPath) | Usual Care Patients |
|---|---|---|
| Started | 188 | 158 |
| Completed | 184 | 156 |
| Not completed | 4 | 2 |
| Withdrew: Withdrawal by subject | 4 | 2 |
| Milestone | Intervention (MyPath) | Usual Care Patients |
|---|---|---|
| Started | 37 | 37 |
| Completed | 34 | 32 |
| Not completed | 3 | 5 |
| Withdrew: No veterans enrolled in study | 3 | 5 |
Self-report of whether a discussion occurred during the scheduled primary care visit about pregnancy goals, prepregnancy health, or contraception that included shared decision making (SDM). SDM is measured by participant self-report with the CollaboRATE scale, which uses three 5-point Likert scale questions to assess SDM (score 0-12, with higher scores indicating more shared decision making; SDM defined using a top box score).
| Participants | Intervention (MyPath) | Usual Care |
|---|---|---|
| Yes (discussion with SDM occurred) | 29 | 20 |
| No (discussion with SDM did not occur) | 139 | 119 |
| Missing (lost to follow-up for the post-visit survey) | 21 | 17 |
| Missing (declined to answer one or more outcome measure questions) | 1 | 3 |
Self-report of whether a discussion of pregnancy goals, prepregnancy health, or contraception occurred during the scheduled primary care visit, regardless of occurrence of SDM.
| Participants | Intervention (MyPath) | Usual Care |
|---|---|---|
| Yes (discussion occurred) | 119 | 93 |
| No (discussion did not occur) | 49 | 49 |
| Missing (lost to follow-up for post-visit survey) | 21 | 17 |
| Missing (declined one or more measure questions) | 1 | 0 |
Assessed with a modified version of the validated 5-item Perceived Efficacy in Patient-Provider Interactions (PEPPI) scale, which uses five Likert scale questions ranging from 1 to 5 (score 5-25, with higher scores indicating higher levels of perceived efficacy).
| Score | Intervention (MyPath) | Usual Care |
|---|---|---|
| Perceived Self-efficacy in Communicating With Providers | 19.8 ± 4.8 | 20.6 ± 4.4 |
Participant responses to 14 items assessing knowledge of fertility, prepregnancy health, and contraception. The measure is self-developed and derived from previously published assessments of fertility and contraceptive knowledge. Responses will be coded as correct vs. incorrect, with "don't know" coded as incorrect (score 0-14, with higher scores indicating more accurate knowledge).
| Number correct | Intervention (MyPath) | Usual Care |
|---|---|---|
| Reproductive Health Knowledge | 7.94 ± 2.64 | 7.89 ± 2.36 |
Assessed with the Decision Conflict Scale (DCS), a validated measure to assess patients' decisional conflict in medical decision making. The DCS includes 16-items with 5-point Likert scale response options ranging from 0-4. Scores are converted to range from 0 (no decisional conflict) to 100 (highest decisional conflict). This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy.
| Score | Intervention (MyPath) | Usual Care |
|---|---|---|
| Contraceptive Decision Conflict | 16.94 ± 17.57 | 20.04 ± 20.67 |
Assessed using a single question ("How confident are you that this contraceptive method is right for you?") with Likert response options from 1 (not at all confident) to 5 (completely confident). This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy.
| Scores on a scale | Intervention (MyPath) | Usual Care |
|---|---|---|
| Confidence That Contraceptive Method is "Right for me." | 4.29 ± 1.05 | 4.29 ± 1.06 |
Self-report of continuing or changing to a prescription or procedural method after their visit. Prescription or procedural methods are defined as any of the following: birth control pills, patch, ring, injection, implants, IUDs, and male and female sterilization. This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy.
| Participants | Intervention (MyPath) | Usual Care |
|---|---|---|
| Prescription or procedural method | 52 | 35 |
| Non-prescription or no method | 25 | 17 |
| Missing (lost to follow-up) | 7 | 10 |
| Missing (did not answer question(s)) | 2 | 2 |
Self-report of continuing or changing to a procedural method after their visit. Procedural methods are defined as any of the following: implants, IUDs, and male and female sterilization. This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy.
| Participants | Intervention (MyPath) | Usual Care |
|---|---|---|
| Procedural method | 28 | 20 |
| Non-procedural or no method | 49 | 32 |
| Missing (lost to follow-up for post-visit survey) | 7 | 10 |
| Missing (did not answer question(s)) | 2 | 2 |
Self-reported use of a prescription or procedural method at follow-up. Prescription or procedural methods are defined as any of the following: birth control pills, patch, ring, injection, implants, IUDs, and male and female sterilization. This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy.
| Participants | Intervention (MyPath) | Usual Care |
|---|---|---|
| Prescription or procedural method | 41 | 28 |
| Non-prescription or no method | 23 | 14 |
| Missing (lost to follow-up 6-month survey) | 22 | 21 |
| Missing (did not answer question(s) due to pregnancy) | 0 | 1 |
Self-reported use of a procedural method at follow-up. Procedural methods are defined as any of the following: implants, IUDs, and male and female sterilization. This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy.
| Participants | Intervention (MyPath) | Usual Care |
|---|---|---|
| Procedural method | 22 | 17 |
| Non-procedural or no method | 42 | 25 |
| Missing (lost to follow-up 6-month survey) | 22 | 21 |
| Missing (did not answer question(s) due to pregnancy) | 0 | 1 |
Self-reported use of a contraceptive method over the past 6 months without a gap of greater than 4 weeks. This combines self-reported use at 3 months and 6 months. This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy. For participants lost to follow-up at the 6 month timepoint, their 6-month values will be singly imputed, carrying forward 3-month continuous use reports when those data are available.
| Participants | Intervention (MyPath) | Usual Care |
|---|---|---|
| Continuous use over 6 months | 62 | 46 |
| Non-continuous use over 6 months | 13 | 6 |
| Missing (lost to follow-up for 6 month survey) | 11 | 11 |
| Missing (did not answer question(s) due to pregnancy) | 0 | 1 |
Self-reported use of a prescription or procedural contraceptive method over the past 6 months without a gap of greater than 4 weeks. Prescription or procedural methods are defined as any of the following: birth control pills, patch, ring, injection, implants, IUDs, and male and female sterilization. This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy.
| Participants | Intervention (MyPath) | Usual Care |
|---|---|---|
| Continuous Use of Rx/Procedural Contraception | 45 | 31 |
| Non-Continuous Use of Rx/Procedural Contraception | 30 | 21 |
| Missing (lost to follow-up for 6-month survey) | 11 | 11 |
| Missing (did not answer question(s) due to pregnancy) | 0 | 1 |
Self-reported use of a procedural contraceptive method over the past 6 months without a gap of greater than 4 weeks. Procedural methods are defined as any of the following: implants, IUDs, and male and female sterilization. This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy.
| Participants | Intervention (MyPath) | Usual Care |
|---|---|---|
| Continuous Use of Procedural Contraception | 27 | 19 |
| Non-continuous Use of Procedural Contraception | 48 | 33 |
| Missing (lost to follow-up for 6-month survey) | 11 | 11 |
| Missing (did not answer question(s) due to pregnancy) | 0 | 1 |
Assessed using a single question ("How satisfied are you with your current birth control method") with Likert response options from 1 (very dissatisfied) to 5 (very satisfied). This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy. While this outcome was measured at 6 months, for participants lost to follow-up at 6 months, we singly imputed these data by pulling forward their 3-month satisfaction, when available.
| Score | Intervention (MyPath) | Usual Care |
|---|---|---|
| Contraceptive Method Satisfaction | 4.28 ± 1.01 | 4.35 ± 0.95 |
Proportion of participants who self-report an unplanned pregnancy, as determined by responses to the 6-item London Measure of Unplanned Pregnancy. The London Measure includes items measuring attitude towards an experienced pregnancy and behaviors before pregnancy to determine the intendedness of pregnancy. The score range of the London Measure is 0-12, with a score of \<10 indicating unplanned pregnancy and a score of 10 or higher indicating planned pregnancy. This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy.
| Participants | Intervention (MyPath) | Usual Care |
|---|---|---|
| Unplanned pregnancy | 0 | 1 |
| No unplanned pregnancy | 64 | 42 |
| Missing (lost to follow-up 6 month survey) | 22 | 21 |
Assessed using a single question ("How confident are you that this contraceptive method is right for you?") with Likert response options from 1 (not at all confident) to 5 (completely confident). This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy.
| Scores on a scale | Intervention (MyPath) | Usual Care |
|---|---|---|
| Confidence That Current Contraceptive Method is "Right for me." | 4.26 ± 0.90 | 4.21 ± 0.98 |
Self-reported contraception use among participants at 6 months that is consistent with their orientation towards pregnancy at 6-months (desires pregnancy now, not trying but OK with it, desires pregnancy later but not now, never desires pregnancy, not sure), regardless of their intention at baseline. This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy. For Veterans who desire pregnancy now, goals-concordant contraceptive use is defined as not using contraception. For Veterans who desire pregnancy later, never, or are unsure, goals-concordant contraceptive use is defined as using contraception. For Veterans who are not trying to get pregnant but would be OK with it, goals-concordant contraceptive use is defined as either using or not using contraception.
| Participants | Intervention (MyPath) | Usual Care |
|---|---|---|
| Yes (goals-concordant contraceptive use) | 50 | 38 |
| No (not goals-concordant contraceptive use) | 14 | 4 |
| Missing (lost to follow-up at 6-months) | 22 | 21 |
| Missing (not asked question(s) due to pregnancy) | 0 | 1 |
Participant responses to 8 items assessing knowledge of contraception. The measure derived from previously published assessments of contraceptive knowledge. Responses will be coded as correct vs. incorrect, with "don't know" coded as incorrect (score 0-8, with higher scores indicating more accurate knowledge).
| Score | Intervention (MyPath) | Usual Care |
|---|---|---|
| Contraceptive Knowledge | 4.42 ± 1.72 | 4.15 ± 1.54 |
Collected over from enrollment through 6 months follow-up. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Intervention (MyPath) Patients | 0/209 (0%) | 0/209 (0%) | 0/209 (0%) |
| Usual Care Patients | 0/182 (0%) | 0/182 (0%) | 0/182 (0%) |
| Intervention (MyPath) Providers | 0/37 (0%) | 0/37 (0%) | 0/37 (0%) |
| Usual Care Providers | 0/37 (0%) | 0/37 (0%) | 0/37 (0%) |
Per the study protocol, enrolled Veterans were excluded from the analytic sample if they were withdrawn from the study prior to any outcomes assessment due to non-attendance at their scheduled primary care visit, pregnancy diagnosed at the scheduled primary care visit, or self-withdrawal prior to outcomes assessment.
| Age, Categorical(Participants) | Intervention (MyPath) Patients | Usual Care Patients | Intervention (MyPath) Providers | Usual Care Providers | Total |
|---|---|---|---|---|---|
| <=18 years | 0 | 0 | 0 | 0 | 0 |
| Between 18 and 65 years | 190 | 159 | 32 | 32 | 413 |
| >=65 years | 0 | 0 | 2 | 0 | 2 |
| Age, Continuous(years of age) | Intervention (MyPath) Patients | Usual Care Patients | Intervention (MyPath) Providers | Usual Care Providers | Total |
|---|---|---|---|---|---|
| Mean | 35.5 (21 to 45) | 35.1 (22 to 45) | 47.7 (29 to 67) | 47.7 (28 to 64) | 37.3 (21 to 67) |
| Sex: Female, Male(Participants) | Intervention (MyPath) Patients | Usual Care Patients | Intervention (MyPath) Providers | Usual Care Providers | Total |
|---|---|---|---|---|---|
| Female | 190 | 159 | 32 | 29 | 410 |
| Male | 0 | 0 | 2 | 3 | 5 |
| Ethnicity (NIH/OMB)(Participants) | Intervention (MyPath) Patients | Usual Care Patients | Intervention (MyPath) Providers | Usual Care Providers | Total |
|---|---|---|---|---|---|
| Hispanic or Latino | 40 | 31 | 4 | 2 | 77 |
| Not Hispanic or Latino | 150 | 128 | 30 | 30 | 338 |
| Unknown or Not Reported | 0 | 0 | 0 | 0 | 0 |
| Race (NIH/OMB)(Participants) | Intervention (MyPath) Patients | Usual Care Patients | Intervention (MyPath) Providers | Usual Care Providers | Total |
|---|---|---|---|---|---|
| American Indian or Alaska Native | 8 | 0 | 0 | 0 | 8 |
| Asian | 3 | 8 | 7 | 11 | 29 |
| Native Hawaiian or Other Pacific Islander | 1 | 1 | 0 | 0 | 2 |
| Black or African American | 84 | 57 | 6 | 5 | 152 |
| White | 67 | 73 | 17 | 13 | 170 |
| More than one race | 12 | 7 | 1 | 0 | 20 |
| Unknown or Not Reported | 15 | 13 | 3 | 3 | 34 |
| Sexual Orientation(Participants) | Intervention (MyPath) Patients | Usual Care Patients | Intervention (MyPath) Providers | Usual Care Providers | Total |
|---|---|---|---|---|---|
| Straight/Heterosexual | 149 | 120 | 0 | 0 | 269 |
| Lesbian/Gay | 14 | 14 | 0 | 0 | 28 |
| Bisexual/Pansexual | 22 | 19 | 0 | 0 | 41 |
| Other | 5 | 6 | 0 | 0 | 11 |
| Missing or Unknown | 0 | 0 | 34 | 32 | 66 |
| Education(Participants) | Intervention (MyPath) Patients | Usual Care Patients | Intervention (MyPath) Providers | Usual Care Providers | Total |
|---|---|---|---|---|---|
| Some high school or GED | 17 | 11 | 0 | 0 | 28 |
| Some college or Associate's Degree | 81 | 61 | 0 | 0 | 142 |
| Bachelor's Degree or Higher | 91 | 87 | 0 | 0 | 178 |
| Missing or Unknown | 1 | 0 | 34 | 32 | 67 |
| Health Insurance Status(Participants) | Intervention (MyPath) Patients | Usual Care Patients | Intervention (MyPath) Providers | Usual Care Providers | Total |
|---|---|---|---|---|---|
| Yes (separate health insurance) | 95 | 65 | 0 | 0 | 160 |
| No (VA coverage only) | 94 | 94 | 0 | 0 | 188 |
| Missing or Unknown | 1 | 0 | 34 | 32 | 67 |
15 further baseline measures are reported on the registry.
Documents are hosted by the registry — open the source record to download them.
Plan to share: Yes — Veteran participant data will be deposited into the "Reproductive, Sexual, and Socio-Behavioral Health Data Repository and Registry" VA data repository and registry housed and managed at the VA Puget Sound Health Care System. The data will be stored indefinitely in accordance with VHA regulations under VA IRB and R\&D Committee oversight. Procedures are as follows.
This study is completed, as verified in Oct 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
VA Office of Research and Development